Siemens Healthineers AG buy kaufmeister
Start price
04.07.22
/
50%
€48.88
Target price
04.07.23
€75.00
Performance (%)
3.76%
End price
05.07.23
€50.72
Summary
This prediction ended on 05.07.23 with a price of €50.72. With a performance of 3.76%, the BUY prediction by kaufmeister for Siemens Healthineers AG closed with a slight gain. Dividends of €0.95 are taken into consideration when calculating the performance. kaufmeister has 50% into this predictionSiemens Healthineers is a multinational medical technology company headquartered in Germany, that provides medical solutions and services to healthcare providers around the world. The company operates in three main segments: imaging, laboratory diagnostics, and advanced therapies, offering a wide range of medical devices and systems, laboratory diagnostics, and digital health solutions to improve patient care and optimize efficiency in the healthcare industry. In addition, Siemens Healthineers is listed on the Frankfurt and US stock exchanges, with a market capitalization of over $70 billion as of 2021, making it one of the largest medical technology companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Siemens Healthineers AG | -5.137% | -5.137% | -3.197% |
| iShares Core DAX® | -1.785% | -1.250% | 11.664% |
| iShares Nasdaq 100 | -2.154% | 0.300% | 37.531% |
| iShares Nikkei 225® | -4.028% | -3.746% | 17.142% |
| iShares S&P 500 | -1.969% | 0.307% | 25.617% |
Comments by kaufmeister for this prediction
In the thread Siemens Healthineers AG diskutieren
Die Privatbank Berenberg hat Siemens Healthineers vor den am 3. August erwarteten Zahlen zum dritten Geschäftsquartal auf "Buy" mit einem Kursziel von 75 Euro belassen. Analyst Odysseas Manesiotis hält die Sorgen am Markt über Gegenwind aus China für unbegründet, wie er in einem am Donnerstag vorliegenden Studie schrieb. Schließlich bedeuteten die Lieferkettenprobleme keinen Nachfrageverlust, und zudem sollten die Schwierigkeiten nur von kurzer Dauer sein. Trotz womöglich schwächerer Quartalszahlen sieht der Experte die Jahresprognose 2021/22 des Medizintechnikkonzerns daher nicht gefährdet
In the thread Trading Siemens Healthineers AG
Die von kaufmeister gewählte maximale Laufzeit wurde überschritten